about
sameAs
A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discoveryThe human plasma proteome: a nonredundant list developed by combination of four separate sourcesHuman plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometryMany accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.Transcriptome and proteome research in veterinary science: what is possible and what questions can be asked?Colorectal cancer screening: tests, strategies, and perspectivesTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsADAMs: key components in EGFR signalling and developmentReverse phase protein microarrays advance to use in clinical trialsCore-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkersBlood peptidome-degradome profile of breast cancerMonitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicDifferential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsAn initial characterization of the serum phosphoproteome.Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.Distributed computing and data storage in proteomics: many hands make light work, and a stronger memory.Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasmaImportance of communication between producers and consumers of publicly available experimental data.Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.A new approach for the analysis of mass spectrometry data for biomarker discoveryCombination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry dataToxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection.Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model.Clinical proteomics and mass spectrometry profiling for cancer detection.Proteomic patterns for cancer diagnosis--promise and challenges.Studying multiple protein profiles over time to assess biomarker validity.Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry.Detection of venous thromboembolism by proteomic serum biomarkers.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.Applications of SELDI-MS technology in oncologyIntegrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.
P2860
Q21135230-D373FE83-9475-4F0D-8ED0-24D69ADD9435Q24304465-FD964534-7D4C-49F5-AB02-01FB6DBE8AF5Q24684774-395E9FC2-35CA-4650-B94B-FA33B87E6EFAQ24798742-218712FD-607F-4C9B-8E76-599C3EC7A67BQ26824312-4F864E2D-E106-420E-8EF6-EFE3748B88AEQ26858827-379E7D52-428C-4F83-8217-AF374304AA76Q28085015-D663600B-7498-4754-9B96-C1CE0BCC592CQ28305519-409A1440-6647-436B-B170-F3D7844D4219Q28384553-13CC5CBA-8627-4A29-90AF-1B641848B7CDQ28474977-15D0CA20-0BE6-4E84-B6E3-D14CE6142CD5Q28475815-7B70C8F1-FA27-4A6D-B7AF-262D189F4A5CQ28483618-1BE9136B-AB68-42AC-87D2-5AB8EA1277B5Q28488743-573DC5D2-985F-4D91-8467-43846717C9F3Q30381604-72D83E1E-EB47-4DD2-A722-E063B356A5D1Q30476027-89ABAB4E-673A-455B-8D0C-4933D6B34B47Q30703115-FF73280E-315E-4F7B-B093-95E350124020Q30751781-38216745-81D9-4223-B3B6-F6928B3935A9Q30835879-D33ED1B8-523A-4B6B-9D05-E880CD45A812Q30982896-547EF67B-4795-4998-8DFF-0247CFC9AC78Q30985472-F1F44F7E-6B74-49F0-B0A8-A682FD7D2B47Q30985505-D0414FBE-EFD0-42CB-A232-E647C83C4EA2Q31039477-C973D70A-3B51-4C8B-9959-103454439890Q31094778-6105E843-AD8E-49E5-A692-01E623BC295CQ31095551-6CFB9293-5C7F-4406-BEE7-81FB2817AD94Q31172638-3CA0DA7A-89BB-47A9-A75A-30441E515BD6Q33204056-701D4A57-7719-4658-B7D8-B5C7A21AB23EQ33217477-4C320AC8-83F2-4684-9AC3-82CE85FB602BQ33217936-1911047E-C4E8-4C1E-BF62-83B2DE2575F5Q33246668-0E653835-FFDD-4E9E-BF74-31BA5B423217Q33252434-4E471E78-292A-43C8-8974-07B56AB6823EQ33253535-B5824F76-0B67-4C07-8438-070D47DACFA3Q33282097-92AED587-47D6-4C0C-B8F8-1E472F06E246Q33288265-10DD090D-365D-4CD4-A588-CD2D73637B78Q33304365-FD4AF107-06F8-48AF-9056-0C73E872CD6EQ33319301-1BE6FD1A-C3C4-400F-9FFD-FDB78422F811Q33382997-581D160C-A414-4539-8742-9AC031112A02Q33467523-E497E4B8-6827-4894-94EF-9B964597882FQ33481276-AA23E024-85A0-409E-BBDE-31EDDF7BD5FAQ33518743-EA774403-370E-43AD-BCE3-3BBAC477230DQ33520447-E4A59029-77B8-4D2F-82FF-1EA7C3E38579
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical proteomics: written in blood
@ast
Clinical proteomics: written in blood
@en
Clinical proteomics: written in blood
@nl
type
label
Clinical proteomics: written in blood
@ast
Clinical proteomics: written in blood
@en
Clinical proteomics: written in blood
@nl
prefLabel
Clinical proteomics: written in blood
@ast
Clinical proteomics: written in blood
@en
Clinical proteomics: written in blood
@nl
P2093
P3181
P356
P1433
P1476
Clinical proteomics: written in blood
@en
P2093
Emanuel Petricoin
Lance A Liotta
Mauro Ferrari
P2888
P3181
P356
10.1038/425905A
P407
P577
2003-10-30T00:00:00Z
P6179
1030299392